CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Guizhou Xinbang Pharmaceutical Company Limited Company Snapshot
Guizhou Xinbang Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Guizhou Xinbang Pharmaceutical Company Limited with three other companies in this sector in China: Zhejiang Medicine Co., Ltd. (2016 sales of 5.28 billion Chinese Renmimbi [US$796.57 million] of which 44% was Life Nourishment), KPC Pharmaceuticals Inc (5.10 billion Chinese Renmimbi [US$769.68 million] of which 47% was Drugs Wholesale and Retail), and China Medical System Holdings Limited (4.90 billion Chinese Renmimbi [US$739.53 million] of which 100% was Pharmaceutical Products).

Sales Analysis. During the year ended December of 2016, sales at Guizhou Xinbang Pharmaceutical Company Limited were 5.16 billion Chinese Renmimbi (US$778.03 million). This is an increase of 23.4% versus 2015, when the company's sales were 4.18 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Guizhou Xinbang Pharmaceutical Company Limited (and since 2011, sales have increased a total of 1,325%). Sales of Corp Farming saw an increase that was more than double the company's growth rate: sales were up 386.8% in 2016, from 5.39 million Chinese Renmimbi to 26.22 million Chinese Renmimbi. Guizhou Xinbang Pharmaceutical Company Limited also saw significant increases in sales in Medicinal Manufacturing (up 41.2% to 903.47 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Guizhou Xinbang Pharmaceutical Company Limited
  Stock Performance Chart for Guizhou Xinbang Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (10/20/2017): 8.54
(Figures in Chinese Renmimbi)
1 Week -1.6%   13 Weeks 0.6%  
4 Weeks 4.0%   52 Weeks -16.9%  
 
Guizhou Xinbang Pharmaceutical Company Limited Key Data:
  Ticker: 002390 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 5,155,906,306
(Year Ending Jan 2017).
Employees: 6,041
  Currency: Chinese Renmimbi Market Cap: 14,559,810,030
  Fiscal Yr Ends: December Shares Outstanding: 1,704,895,788
  Share Type: A Gu Closely Held Shares: 919,321,506
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.